The primary therapeutic role of Cataflam Dispersable (Diclofenac Potassium) is to provide short-term symptomatic relief from pain, inflammation, and fever across specific clinical situations where symptoms are heightened. In this capacity, the medication is applied for relief from tenderness, swelling, and stiffness caused by various conditions.

---

Key Therapeutic Domains and Symptom Relief

This medication is applied in managing symptoms related to inflammatory or irritative states across several domains, including painful flare-ups of chronic conditions like rheumatoid arthritis and osteoarthritis, as well as acute episodes of musculoskeletal disorders. It is also relevant for managing acute pain and swelling following physical trauma such as sprains and strains, and during the postoperative recovery period. Additionally, it is used in addressing intense, time-limited symptom patterns such as the pronounced discomfort of primary dysmenorrhea (menstrual pain) and challenging symptoms associated with acute migraine episodes. The core therapeutic benefit is to ease the functional strain and support daily mobility and comfort.

---

Quick Fact: Relief for Inflammatory Discomfort

Quick Fact: Relief for Inflammatory Discomfort
Primary Focus	Symptoms related to inflammatory or irritative states.
Benefit	Contributes to easing the overall symptom burden during periods of heightened symptoms.
Context	Applied when short-term symptomatic assistance is needed.

Regulatory References

1. NIH MedlinePlus overview

Who Can and Cannot Use Cataflam Dispersable?

This medication is officially designated for adults who do not possess specific health conditions that make its use unsafe. Eligibility is defined by regulatory agencies based on age, medical history, and overall organ function.

---

Populations for Whom Use is Prohibited (Contraindications):

Cataflam Dispersable must not be used by patients who have any of the following:

• A known hypersensitivity or allergic reaction to the active ingredient, diclofenac, or any history of asthma, urticaria, or allergic reactions triggered by aspirin or other NSAIDs.
• Active gastrointestinal ulceration, bleeding, or perforation.
• Severe failure of key organs, including severe hepatic failure, severe renal failure, or severe cardiac failure.
• Treatment of pain associated with Coronary Artery Bypass Graft (CABG) surgery.
• The last trimester of pregnancy.

---

Age and Other Restrictions:

The product is generally not recommended for use in children and adolescents typically below 14 years of age. Use in the elderly requires special caution due to an increased risk of adverse reactions.

Interactions with other medicines and products

This section outlines interactions with other medicinal products and substances as officially documented in regulatory prescribing information for Diclofenac Potassium, the active ingredient in Cataflam Dispersable.

Official Restrictions and Contraindicated Combinations

Co-administration with Aspirin or other systemic Nonsteroidal Anti-inflammatory Drugs (NSAIDs) is officially discouraged due to a documented increased risk of serious gastrointestinal adverse effects. Furthermore, use is contraindicated for the treatment of peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.

---

Documented Pharmacokinetic and Pharmacodynamic Interactions

Exposure Modification

Interacting Substance	Official Interaction Outcome
Lithium or Digoxin	May increase plasma concentrations of the co-administered drug.
Methotrexate	May increase serum levels of methotrexate by reducing its renal clearance.
CYP2C9 Inhibitors	Co-administration may enhance Diclofenac's systemic exposure.

Pharmacodynamic Effects

Diclofenac may reduce the efficacy of Diuretics and Angiotensin-Converting Enzyme (ACE) Inhibitors or Angiotensin Receptor Blockers (ARBs), consistent with its effect on renal prostaglandin synthesis. Concomitant use with Anticoagulants (e.g., Warfarin), Antiplatelet Agents, or SSRIs/SNRIs results in a pharmacodynamically reinforced risk of bleeding.

Substance and Population Notes

Alcohol consumption is documented to increase the risk of serious gastrointestinal bleeding. Interactions leading to serious gastrointestinal events are associated with a greater risk in elderly patients.

How Cataflam Dispersable Works

---

Targeted Inhibition of Prostaglandin Synthesis

The core mechanism involves the competitive inhibition of Cyclooxygenase ( COX) enzymes, targeting the COX-2 isoform with greater potency. This interaction blocks the conversion of arachidonic acid into prostanoid mediators, primarily prostaglandins ( PGE2). By diminishing the local supply of these chemical messengers, the drug modulates pathways characterized by heightened inflammatory mediator production.

---

Modulation of Peripheral Nociceptive Signaling

The reduction in PGE2 concentration leads to the de-sensitization of peripheral nerve endings (nociceptors). This decreases the excitability of peripheral sensory neurons, altering subsequent signaling dynamics. Simultaneously, lowering the PGE2 levels in vascular tissue limits local capillary permeability and fluid exudation, which reduces the volume of interstitial fluid.

---

Central Thermoregulatory Modulation

Systemically, the reduction of PGE2 within the hypothalamus removes the signal that elevates the body's central temperature set-point. This permits the central thermal control mechanism to return the elevated set-point to baseline, resulting in a regulated decrease of core body temperature. The potassium salt formulation promotes rapid systemic availability, mechanically accelerating the engagement of COX enzyme inhibition throughout the body.

How to Use Cataflam Dispersable: Official Administration Guidelines

Cataflam Dispersable (diclofenac potassium) is for oral administration and must be prepared and taken according to a specific procedure outlined in regulatory labeling.

Preparation and Ingestion

1. Dispersion: Drop the dispersible tablet (or the contents of a sachet) into a glass containing a small amount of natural (non-carbonated) water (e.g., 10 mL to 30 mL) and stir until the tablet is fully dispersed. The resulting solution may be slightly cloudy, but this does not affect its efficacy.
2. Swallowing: Swallow the liquid immediately. To ensure the full dose is received, it is advised to rinse the glass with a small additional amount of water and swallow the rinse as well.
3. Timing: The solution should preferably be swallowed before meals (on an empty stomach).

Official Dosing Rules

As a general recommendation, the total daily dose should be divided into 2 or 3 separate doses. Dosing must adhere to the principle of using the lowest effective dose for the shortest duration necessary to manage symptoms. The maximum daily dosage for adults and adolescents (14 years and older) should generally not exceed 150 mg, although higher limits (up to 200 mg) may be specified for certain acute conditions (e.g., migraine).

If a dose is missed, it should be taken as soon as remembered, unless it is almost time for the next scheduled dose. In this event, the missed dose should be skipped, and the patient should resume the regular dosing schedule; a double dose should never be taken to compensate for the missed one. The use of Cataflam Dispersable is not recommended for children and adolescents below 14 years of age.

Recent Clinical Evidence Overview

Cataflam Dispersable (diclofenac potassium) is a non-steroidal anti-inflammatory drug (NSAID) formulated for rapid absorption. Clinical research on the dispersible potassium salt formulation has primarily focused on its use in acute pain conditions, where a fast onset of action may be beneficial.

---

Acute Pain Studies

Studies have investigated the drug's effect in relieving moderate to severe pain, particularly following procedures like dental surgery or in cases of minor sports injuries. A key finding in trials comparing diclofenac potassium dispersible to other analgesic formulations relates to the time frame of observed pain relief.

Area of Investigation	Key Research Finding (Reported)
Onset of Effect	Some trials noted early effects on pain scores, with measurable plasma levels of the active substance sometimes observed within 10 minutes of dosing.
Postoperative Pain	In several randomized controlled trials, diclofenac potassium (50 mg single dose) demonstrated findings of pain relief that were considered statistically significant compared to placebo in adults with moderate to severe pain.

---

Comparative Trials and Adverse Events

Comparative studies have evaluated the findings related to this drug against results from standard care protocols. For instance, in one study of patients with acute minor sports injuries, the diclofenac dispersible formulation was studied alongside naproxen granular, noting differences in reported pain intensity and pain relief scores over a four-hour period.

Research confirms that like all NSAIDs, the use of diclofenac carries a risk of serious cardiovascular and gastrointestinal adverse events, especially with long-term or high-dose use. Clinical trials generally assess adverse event rates to monitor the overall safety profile of the drug in studied populations.

Key Studies & References

1. NICE Guideline NG19: Managing common conditions causing pain in older people

Common questions about Cataflam Dispersable (FAQ)

Q: What is Cataflam Dispersable used for?

Cataflam Dispersable is a medication known as a Non-Steroidal Anti-Inflammatory Drug (NSAID). It is primarily used for the short-term treatment of pain and inflammation associated with various acute conditions.

• Acute Pain: Including pain from injuries, dental procedures, and post-operative pain.
• Painful Menstrual Periods (Primary Dysmenorrhea): Used to relieve pain associated with the menstrual cycle.
• Rheumatoid Arthritis and Osteoarthritis: May be used to relieve signs and symptoms of these conditions.

Q: How do I prepare and take the dispersible tablet?

Cataflam dispersible tablets should be dropped into a glass of water (natural, non-carbonated). The liquid should be stirred to help the tablet disperse before swallowing the solution.

• Swallowing: The entire solution should be swallowed immediately. Because some of the medicine may remain in the glass, it is advisable to rinse the glass with a small amount of water and swallow that liquid as well.
• Timing: It is often recommended to take this medicine preferably before meals for optimal absorption.
• Do Not: The dispersible tablets should not be divided, chewed, or sucked.

Q: Who should not take Cataflam Dispersable?

Cataflam Dispersable is not suitable for everyone. Do not take this medicine if you have any of the following conditions:

• Allergy: If you are allergic to diclofenac (the active ingredient), other NSAIDs (such as aspirin or ibuprofen), or any other ingredients in the tablet.
• Stomach/Intestinal Bleeding or Ulcers: If you have an active stomach ulcer, bleeding, or perforation of the stomach or intestines.
• Heart Problems: If you have severe heart failure, or have had a recent heart attack or stroke, or have severe peripheral arterial disease.
• Liver or Kidney Disease: If you suffer from severe liver or kidney disease.
• Coronary Artery Bypass Graft (CABG) Surgery: Do not take it right before or after heart bypass surgery.
• Pregnancy/Breastfeeding: The use of diclofenac is generally contraindicated in the last trimester of pregnancy and during breastfeeding.

Q: Does this medicine contain sodium?

Yes, Cataflam Dispersable contains a very small amount of sodium. However, it typically contains less than 1 mmol (23 mg) of sodium per tablet, which means it is considered essentially 'sodium-free' from a medicinal product labeling standpoint.

Official Storage and Disposal Requirements

The regulatory profile for Cataflam Dispersable (diclofenac potassium) outlines strict conditions for storage and disposal to maintain stability and prevent environmental harm.

Storage Constraints:

Condition	Requirement
Temperature	Store at or below 30 C (varies by region).
Protection	Keep in the original packaging to protect from moisture.
Stability	The solution, once prepared by dissolving the tablet in water, must be swallowed immediately.
Safety	Keep the medicine out of the sight and reach of children at all times.

Disposal Rules:

Official instructions prohibit disposing of unused or expired medicine via wastewater or household trash. To protect the environment, the product should be taken to a pharmacy or an authorized medicine take-back program for proper disposal, avoiding release to sewers and public waters.